COMMUNIQUÉS West-GlobeNewswire

DBV Technologies annonce les résultats de l'étude de Phase II de Viaskin Milk chez les patients allergiques au lait

26/02/2018 - 23:06

DBV Technologies annonce les résultats de l'étude de Phase II de Viaskin Milk chez les patients allergiques au lait Les résultats préliminaires sont positifs et Viaskin Milk pourrait être le premier traitement potentiel [...]

DBV Technologies Announces Results from Phase II Study of Viaskin Milk in Milk-Allergic Patients

26/02/2018 - 23:01

Press Release Montrouge, France, February 26, 2018 DBV Technologies Announces Results from Phase II Study of Viaskin Milk in Milk-Allergic Patients Positive preliminary results support Viaskin Milk's potential as the [...]

DBV Technologies annonce les résultats de l'étude de Phase II de Viaskin Milk chez les patients allergiques au lait

26/02/2018 - 23:01

Communiqué de presse Montrouge, France, le 26 février 2018 (22h30 CET) DBV Technologies annonce les résultats de l'étude de Phase II de Viaskin Milk chez les patients allergiques au lait Les résultats préliminaires sont [...]

Flexion Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 8, 2018

26/02/2018 - 22:30

BURLINGTON, Mass., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that it will report its fourth quarter and full year 2017 financial results after the close of the U.S. [...]

EMERGENT BIOSOLUTIONS AND VALNEVA INITIATE PHASE 1 CLINICAL STUDY TO EVALUATE VACCINE CANDIDATE AGAINST ZIKA VIRUS

26/02/2018 - 22:22

EMERGENT BIOSOLUTIONS AND VALNEVA INITIATE PHASE 1 CLINICAL STUDY TO EVALUATE VACCINE CANDIDATE AGAINST ZIKA VIRUS GAITHERSBURG, Md. and LYON, France, February 26, 2018 - Emergent BioSolutions Inc. (NYSE: EBS) and [...]

EMERGENT BIOSOLUTIONS ET VALNEVA INITIENT UNE ETUDE CLINIQUE DE PHASE I POUR EVALUER LEUR CANDIDAT VACCIN CONTRE LE VIRUS ZIKA

26/02/2018 - 22:22

EMERGENT BIOSOLUTIONS ET VALNEVA INITIENT UNE ETUDE CLINIQUE DE PHASE I POUR EVALUER LEUR CANDIDAT VACCIN CONTRE LE VIRUS ZIKA GAITHERSBURG, Md. et LYON, France, 26 février 2018 - Emergent BioSolutions Inc. (NYSE: EBS) [...]

Almost Family Reports Fourth Quarter and Full Year 2017 Results

26/02/2018 - 22:22

LOUISVILLE, Ky., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Almost Family, Inc. (NASDAQ: AFAM ), a leading provider of home health and related services, announced today its financial results for the quarter and year ended [...]

Alder BioPharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial and Operating Results

26/02/2018 - 22:15

– Strong cash position to support eptinezumab development through approval and commercial launch – – Recently reported pivotal PROMISE 2 top-line data in chronic migraine demonstrates eptinezumab significantly reduced [...]

Emergent BioSolutions and Valneva Initiate Phase 1 Clinical Study to Evaluate Vaccine Candidate Against Zika Virus

26/02/2018 - 22:15

GAITHERSBURG, Md. and LYON, France, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) and Valneva SE (Euronext Paris:VLA) today announced the initiation of a Phase 1 clinical trial in the U.S. to [...]

HTG Announces New Australian Patent for Its Technology

26/02/2018 - 22:05

Patent covers methods of co-detecting mRNA and small non-coding RNA TUCSON, Ariz., Feb. 26, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM ), a provider of instruments, reagents, and services for [...]

OPKO Health to Announce Fourth Quarter and Year End 2017 Financial Results on March 1, 2018

26/02/2018 - 22:05

MIAMI, Feb. 26, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK ), plans to announce its operating and financial results for the three and twelve months ended December 31, 2017, after the close of the U.S. [...]

Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2017

26/02/2018 - 22:05

Preparing for mid-2018 approval and launch of volanesorsen for FCS in the US, EU and Canada Advancing the pipeline with four Phase 2 trials underway and data planned from two studies in 2018 Conference Call Webcast [...]

Antares Pharma to Present at the Raymond James & Associates 39th Annual Institutional Investors Conference

26/02/2018 - 22:01

EWING, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Raymond James & Associates 39th [...]

Collegium to Host Conference Call to Discuss Fourth Quarter 2017 Financial Results and Provide Corporate Update

26/02/2018 - 22:01

CANTON, Mass., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL ) announced today that the Company will host a conference call and live audio webcast on Wednesday, March 7, 2018 at 4:30 p.m [...]

Tyme Technologies Announces Offering of Common Stock

26/02/2018 - 22:01

NEW YORK, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ) (the “Company”), a clinical-stage biotechnology company developing cancer therapeutics, today announced that it had commenced an [...]

2018 First Half Year Financial Results Webcast for Mesoblast

26/02/2018 - 22:00

NEW YORK and MELBOURNE, Australia, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO ) (ASX:MSB) today announced it will report financial results for the first half year ended December 31, 2017 in a [...]

Healthwise Announces Elizabeth Beem as Chief Financial Officer

26/02/2018 - 21:01

BOISE, Idaho, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Healthwise, a leader in evidence-based health education, technology and services, announced that Elizabeth Beem will assume the position of Chief Financial Officer (CFO). [...]

TESARO Announces Collaboration to Evaluate Combination of ZEJULA® (Niraparib) and Anti-PD-L1 Cancer Immunotherapy in Metastatic Bladder Cancer

26/02/2018 - 21:00

WALTHAM, Mass., Feb. 26, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced that it has entered into a clinical collaboration with Genentech, a member [...]

SuperSonic Imagine to present Aixplorer® Ultimate at the European Congress of Radiology (ECR 2018)

26/02/2018 - 20:00

AIX-EN-PROVENCE, France, Feb. 26, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today it will be presenting its premium [...]